Align Aspartate kinase Ask_LysC; Aspartokinase; EC 2.7.2.4 (characterized)
to candidate CCNA_00886 CCNA_00886 aspartokinase
Query= SwissProt::A4VJB4 (412 letters) >lcl|FitnessBrowser__Caulo:CCNA_00886 CCNA_00886 aspartokinase Length = 415 Score = 392 bits (1008), Expect = e-114 Identities = 221/415 (53%), Positives = 287/415 (69%), Gaps = 13/415 (3%) Query: 1 MALIVQKFGGTSVGTVERIEQVAEKVKKFRDGGDDIVVVVSAMSGETNRLIDLAKQISEQ 60 M+ +V KFGGTSV +ERI +VA V G + VVVSAMSG+TN L+ Sbjct: 1 MSRLVMKFGGTSVADLERIRRVARLVAAEVATGKQVAVVVSAMSGKTNELVAWTDGAGRA 60 Query: 61 PV-----PRELDVMVSTGEQVTIALLAMALIKRGVPAVSYTGNQVRILTDSAHTKARILQ 115 E D +V++GEQVT LLAM L G A S+ G QV ILTD AH +ARI + Sbjct: 61 AAGLPESDDEYDAVVASGEQVTAGLLAMTLRNMGHKARSFLGWQVPILTDEAHGRARIEE 120 Query: 116 IDAQRIQRDIKAGRVVVVAGFQGVDEKGNITTLGRGGSDTTGVALAAALKADECQIYTDV 175 I + ++ G + V+AGFQGV ITTLGRGGSDT+ VA+AAA+K D C IYTDV Sbjct: 121 IPPENLEECFANGEIAVIAGFQGVTPNRRITTLGRGGSDTSAVAIAAAVKGD-CDIYTDV 179 Query: 176 DGVYTTDPRVVAKAQRLDKITFEEMLEMASLGSKVLQIRAVEFAGKYSVPLRVLHSFQE- 234 DGVYTTDPR+ +KA+RL KI++EEMLEMASLG+KVLQ R+VE A + VP+RVL SF E Sbjct: 180 DGVYTTDPRIESKARRLAKISYEEMLEMASLGAKVLQTRSVEMAMAHRVPVRVLSSFVEP 239 Query: 235 ----GPGTLITLDEEESMEQPIISGIAFNRDEAKLTIRGVPDTPGVAFKILGPISAANVE 290 G GT++ DEEE ME+ I+SG+A++RDEAK+T+ G+PD PGV+ +I G ++ ANV Sbjct: 240 GEAPGQGTIVC-DEEEIMEKRIVSGVAYSRDEAKITLLGLPDHPGVSSQIFGRLAEANVN 298 Query: 291 VDMIVQNVAHD-NTTDFTFTVHRNDYNNALQVLQGIAAEMGAREAIGDTNIAKVSIVGVG 349 VDMIVQ+ A +T + FTV + D A++++Q E+G + ++AKVS++GVG Sbjct: 299 VDMIVQSRARSADTANMEFTVGKRDATRAVEIVQAAQKEIGFEAVAVNEDVAKVSVIGVG 358 Query: 350 MRSHAGVASRMFEALAKENINIQMISTSEIKVSVVIEEKYLELAVRALHTAFELD 404 MRSHAGVA MF+ALA++NINIQ+ISTSEIK+SV+I+ Y ELAVRALH + LD Sbjct: 359 MRSHAGVAQSMFQALAEKNINIQVISTSEIKISVLIDAAYTELAVRALHAVYGLD 413 Lambda K H 0.317 0.133 0.357 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 445 Number of extensions: 22 Number of successful extensions: 6 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 412 Length of database: 415 Length adjustment: 31 Effective length of query: 381 Effective length of database: 384 Effective search space: 146304 Effective search space used: 146304 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.6 bits) S2: 50 (23.9 bits)
Align candidate CCNA_00886 CCNA_00886 (aspartokinase)
to HMM TIGR00656 (aspartate kinase, monofunctional class (EC 2.7.2.4))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR00656.hmm # target sequence database: /tmp/gapView.8237.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR00656 [M=407] Accession: TIGR00656 Description: asp_kin_monofn: aspartate kinase, monofunctional class Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 5.6e-132 426.5 10.4 6.3e-132 426.3 10.4 1.0 1 lcl|FitnessBrowser__Caulo:CCNA_00886 CCNA_00886 aspartokinase Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__Caulo:CCNA_00886 CCNA_00886 aspartokinase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 426.3 10.4 6.3e-132 6.3e-132 4 405 .. 4 411 .. 1 413 [. 0.94 Alignments for each domain: == domain 1 score: 426.3 bits; conditional E-value: 6.3e-132 TIGR00656 4 iVqKFGGtsvgsserikkaakivlkelkegkkvvVVvSAmskvtdelvelaellklleaisdei....sprer 72 V+KFGGtsv++ eri+++a++v +e+ gk+v VVvSAms++t+elv+ ++ a + + s+ e lcl|FitnessBrowser__Caulo:CCNA_00886 4 LVMKFGGTSVADLERIRRVARLVAAEVATGKQVAVVVSAMSGKTNELVAWTDG-----AGRAAAglpeSDDEY 71 69*************************************************82.....2222223334899** PP TIGR00656 73 delvsvGEllssallssalrelgvkaealdgkeagilTddefgnAkikelateerLlelLeegiivvvaGFiG 145 d +v+ GE++++ ll++ lr+ g+ka+++ g++ +ilTd+ +g+A+i+e+ + e+L+e ++g i v+aGF+G lcl|FitnessBrowser__Caulo:CCNA_00886 72 DAVVASGEQVTAGLLAMTLRNMGHKARSFLGWQVPILTDEAHGRARIEEIPP-ENLEECFANGEIAVIAGFQG 143 ****************************************************.******************** PP TIGR00656 146 ateeGeiTtLGRGGSDltAallaaalkAdrveiyTDVeGvyttDPrvveeakkidkisyeEalelAtlGakvl 218 t + +iTtLGRGGSD++A+++aaa+k d ++iyTDV+GvyttDPr+ ++a++++kisyeE+le+A+lGakvl lcl|FitnessBrowser__Caulo:CCNA_00886 144 VTPNRRITTLGRGGSDTSAVAIAAAVKGD-CDIYTDVDGVYTTDPRIESKARRLAKISYEEMLEMASLGAKVL 215 ***************************76.9****************************************** PP TIGR00656 219 hpralelaveakvpilvrssk.....ekeegTlitnkkens..slvkaialeknvarltvegegmlgkrgila 284 + r++e+a++ vp++v ss+ + +gT +++++e ++v+++a++++ a++t+ g+ +++g+ + lcl|FitnessBrowser__Caulo:CCNA_00886 216 QTRSVEMAMAHRVPVRVLSSFvepgeAPGQGTIVCDEEEIMekRIVSGVAYSRDEAKITLL--GLPDHPGVSS 286 *****************9997433323459*****955533348*****************..99******** PP TIGR00656 285 eifkaLaeeeinvdlisqtese....tsislvvdeedvdeakkaLkeesgaaelesleveedlavvsivgagl 353 +if++Lae+++nvd+i+q++++ +++++v ++d+++a+++ ++ ++++++e + v+ed+a+vs++g+g+ lcl|FitnessBrowser__Caulo:CCNA_00886 287 QIFGRLAEANVNVDMIVQSRARsadtANMEFTVGKRDATRAVEIVQAAQKEIGFEAVAVNEDVAKVSVIGVGM 359 ********************99989889********************************************* PP TIGR00656 354 veapGvaseifkaleekninilmisssetkisvlvdekdaekavrklhekle 405 +++ Gva+ +f+al+eknini is+se+kisvl+d +++e avr+lh+++ lcl|FitnessBrowser__Caulo:CCNA_00886 360 RSHAGVAQSMFQALAEKNINIQVISTSEIKISVLIDAAYTELAVRALHAVYG 411 ************************************************9985 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (407 nodes) Target sequences: 1 (415 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.02u 0.01s 00:00:00.03 Elapsed: 00:00:00.01 # Mc/sec: 9.66 // [ok]
This GapMind analysis is from Aug 03 2021. The underlying query database was built on Aug 03 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code, or see changes to Amino acid biosynthesis since the publication.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory